Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02581982
Title Paclitaxel and Pembrolizumab in Treating Patients With Refractory Metastatic Urothelial Cancer
Recruitment Completed
Gender both
Phase Phase II
Variant Requirements No
Sponsors Comprehensive Cancer Center of Wake Forest University
Indications
Therapies
Age Groups: adult
Covered Countries USA


No variant requirements are available.